Megha Mendiratta, MD
Family Medicine · Washington, DCNPI 1184985418
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,795 of the $6,015 with a category attached, or 79.7%. 32 manufacturers reported payments, led by AbbVie at 24.4% of the total. Reporting peaked in 2021 at $1,809 and has fallen 78.6% since, to $387 in 2025. Among family medicine clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $25.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$1K
- Gilead$498
- Pfizer$332
- Takeda Pharmaceuticals U.S.A., Inc.$309
- Biohaven Pharmaceutical Holding Company Ltd.$289
- plus $2K from 26 others
What the payments were for
- Consulting fees$1,20020%
- Travel & lodging$200%
- Food & beverage$4,79580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 78 | $1,467 |
| Biohaven Pharmaceuticals, Inc. | 6 | $1,303 |
| Gilead | 21 | $498 |
| Pfizer | 17 | $332 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $309 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $289 |
| Bausch Health US, LLC | 17 | $288 |
| Merck | 9 | $278 |
| AstraZeneca | 4 | $189 |
| Therapeuticsmd, Inc. | 5 | $118 |
| Viiv Healthcare Company | 4 | $106 |
| GSK | 6 | $102 |
| Lilly USA, LLC | 4 | $83 |
| Amgen | 3 | $78 |
| Amarin Pharma, Inc. | 3 | $61 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Axogen | 1 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $40 |
| Tris Pharma Inc | 2 | $39 |
| Neos Therapeutics, LP | 2 | $39 |
| Bayer | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Phadia US Inc. | 2 | $30 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
| Exact Sciences | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Aerin Medical Inc. | 1 | $20 |
| Abbott | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- AIRSUPRA$126
- Descovy$124
How this compares
$6,015 in reported general payments places this provider in the 95th percentile of 166 family medicine providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $1,242 |
| Rosuvastatin Calcium | 35 | $1,233 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $277 |
| Omeprazole | 13 | $171 |
| Levothyroxine Sodium | 19 | $165 |
| Metoprolol Succinate | 14 | $145 |
| Ezetimibe | 14 | $143 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $86 |
| Amlodipine Besylate | 34 | $78 |
| Atorvastatin Calcium | 19 | $52 |
| Losartan Potassium | 11 | $44 |
| Clonazepam | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Washington
- Mark JohnsonWashington$38K
- Charles GreenWashington$25K
- Barry ClarkWashington$17K
- Joel AngWashington$14K
- Kandie TateWashington$12K
- Ghulam AbbasWashington$9K
- Minerva CamposWashington$5K
- Kathleen UhlWashington$5K
- Mikel HofmannWashington$4K
- Kyle BendaWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.